Lower use of imaging seen in the VA than in fee-for-service Medicare; not associated with less geographic variation.
Researchers found that non-hospice patients used significantly more health care resources, mainly for acute conditions not directly related to their cancer.
A summary of site, platform, and social media use by oncologists in 2014.
Presence of residual vein thrombosis may help determine the optimal duration of anticoagulant therapy in cancer patients with deep vein thrombosis (DVT) of the lower limbs.
[Cancer Control] Age has in impact on the biology of cancer, treatment goals, and barriers to treatment. Older patients are also currently under-represented in clinical trials, but this need not be the case.
Shorter time to testosterone recovery with 18 versus 36 months androgen deprivation therapy.
More than 25% of hospital medicine services were rated by ordering physicians as at least a partially defensive order, according to recent data.
Animal assisted interventions such as visits from therapy dogs and patients' pets are proven to improve patient outcomes.
New multiple myeloma treatment options have shown promise for patients aged 65 years and younger and for newly diagnosed individuals ineligible for stem-cell transplantation, according to two studies.
For patients with cancer, late admission more likely for younger patients, married men, hematologic malignancies.
Patients with Medicaid insurance or no insurance coverage are less likely to receive cancer-related surgery and/or radiation and are more likely to die from cancer than those with insurance, according to an online study.
Researchers devised an intervention that quickly integrates a cancer support team to guide caregivers and their patients through difficult end-of-life treatment and decisions.
A research team has created a new, self-assembling nanoparticle that can increase the effectiveness of magnetic resonance imaging (MRI) cancer detection.
In advanced cancer patients receiving opioids, methylprednisolone does not add to analgesic effect.
Physicians who diagnosed low-risk prostate cancer had more influence over the decision to enter active surveillance than did the disease characteristics, according to a case review.
HIV-infected individuals with cancer are less likely to receive treatment, according to a study published online in the Journal of Clinical Oncology.
Long-term central venous catheters (CVCs) are associated with an increased risk of infection in older adults with cancer, according to research published online.
Researchers have found that as antihistamines do their job, they also interfere with the function of myeloid-derived suppressor cells—a type of cell known to hinder the body's ability to combat tumors.
A landmark survey of more than 700 specialists provides crucial real-world insight into the treatments that most oncologists choose for lung cancer patients whose tumor has been incompletely resected.
A simple, noninvasive blood test matched with state-of-the-art molecular imaging of individual cells could help oncologists understand their patients' chances of survival.
Specialists who treat prostate cancer agree that active surveillance is an effective option—yet according to a study most don't recommend it when appropriate for their own patients.
A pilot program demonstrated that an acuity tool that accounts for more complex ambulatory infusion treatments allows nurses to increase their productivity.
A communication skills training program based on patient preferences regarding communication can help oncologists' communication performance, according to a study.
A national survey of patients reveals that physicians don't always fully discuss the risks and benefits of cancer screening, reports a new study.
People who survive cancer are likely to face a lifelong drain on their finances as they pay for mounting medical expenses year after year, a new government report finds.
One in five cancer patients typically wait more than three months to check in with a doctor about potentially serious symptoms, according to a new study.
Evidence to support reimbursement for proton-beam therapy remains limited to several relatively uncommon cancers.
Despite claims suggesting otherwise, inappropriate cancer patient demands are few and very rarely lead to unnecessary tests and treatments from their health care providers, according to new results.
New study challenges belief that inappropriate cancer treatments fuel health care costs, researcher says.
It is important to recognize and treat anxiety or depression among cancer patients, according to a clinical guideline published in the Journal of Clinical Oncology.
- Key discovery in understanding successes and failures of immunotherapy
- Researchers identify biological indicator of response to new ovarian cancer drug
- Managing obesity should be part of cancer care
- Galeterone active in one form of castration-resistant prostate cancer
- Reducing side effects of everolimus administration
- Navigation and survivorship: Rationalizing your program costs
- Monitoring psychosocial function in radiotherapy
- Comparison of medications for managing nausea and vomiting
- Comparison of constipation management medications
- Chemo- and immunotherapy combination is a promising treatment for pancreatic cancer
- High tumor immune cell levels may identify women with HER2+ breast cancer who may benefit from chemotherapy alone
- Hair Dyes and Cancer Risk (Fact Sheet)
- For bladder cancer, laparoscopic radical cystectomy effective at preventing recurrence
- Aspirin and/or NSAID use may improve risk of high-grade prostate cancer
- Modifying lifestyle, HPV vaccine can help prevent anal cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|